Advertisements



We are Sorry, This Page doesn't Exist


Inovio"s stock is up after it shares new data from Phase 2 clinical trial for its COVID-19 vaccine candidate

Shares of Inovio Pharmaceuticals Inc. gained 8.0% in premarket trading on Monday after the company said its experimental COVID-19 vaccine was safe and also triggered antibody titers in 400 or so adult participants in a P.....»»

Category: topSource: marketwatchMay 10th, 2021

Inovio stock plunges after U.S. government stops funding of Phase 3 trial of COVID-19 vaccine candidate

Shares of Inovio Pharmaceuticals Inc. plunged 29.7% toward a 13-month low, enough to pace all premar.....»»

Category: topSource: marketwatchApr 23rd, 2021

Accel Research Sites continues "important global work" and adds jobs as Covid vaccine trials continue

The company is working on several Covid-related trials, including for a number of vaccines.....»»

Category: topSource: bizjournalsMar 25th, 2021

Inovio Shares Rise On Positive Data For Coronavirus Vaccine Candidate That"s Stable At Room Temps

Inovio Pharmaceuticals Inc (NASDAQ: INO) shares were trading higher Thursday after the company released positive Phase 1 data on to its COVID-19 DNA vaccine candidate. read more.....»»

Category: blogSource: benzingaDec 24th, 2020

Coronavirus deaths in the U.S. are likely higher than the official tally, Dr. Fauci tells Senate committee

Government health officials sought to assure critical Democratic lawmakers that COVID-29 testing capacity is on track to increase as questions persist about how reopening state economies will work without a vaccine or widespread treatment options......»»

Category: topSource: marketwatchMay 12th, 2020

Inovio to expand manufacturing of COVID-19 vaccine candidate with new CEPI grant

Inovio Pharmaceuticals Inc. said Thursday it has .....»»

Category: topSource: marketwatchApr 30th, 2020

NY pharma titans join federal agencies to speed treatment, vaccine work

Manhattan-based pharmaceutical giants Pfizer and Bristol Myers Squibb are among more than a dozen industry partners that have joined federal health agencies in the newly created Accelerating Covid-19... To view the full story, click the title link......»»

Category: blogSource: crainsnewyorkApr 21st, 2020

Inovio gets additional $6.9M for clinical trials of COVID-19 vaccine candidate

The Coalition for Epidemic Preparedness Innovations is providing $6.9 million to Inovio Pharmaceuticals to conduct clinical testing of its experimental COVID-19 vaccine in South Korea. Under the funding agreement, Plymouth Meeting-based Inovio (NA.....»»

Category: topSource: bizjournalsApr 16th, 2020

Inovio to begin human testing of its experimental COVID-19 vaccine

Inovio Pharmaceuticals Inc. plans to begin human testing of its coronavirus vaccine candidate Monday — making it among the first biopharmaceutical companies to accomplish that goal. The Plymouth Meeting company's stock was trading up more than 3% at $7.....»»

Category: topSource: bizjournalsApr 6th, 2020

Inovio Pharmaceuticals plans first dosing of patients in trial of DNA COVID-19 vaccine candidate on Monday

Inovio Pharmaceuticals Inc. is planning the first dosing of patients in a Phase 1 trial of its DNA vacci.....»»

Category: topSource: marketwatchApr 6th, 2020

Here"s Every Vaccine And Treatment In Development For COVID-19, So Far

Here's Every Vaccine And Treatment In Development For COVID-19, So Far As the number of confirmed COVID-19 cases continues to skyrocket, healthcare researchers around the world are working ti.....»»

Category: blogSource: zerohedgeApr 3rd, 2020

Inovio and Ology Bioservices awarded $11.9 million contract from DoD to work on COVID-19 vaccine

Inovio Pharmaceuticals Inc. and privately held Ology Bioservices Inc. said Tuesday they have been awarded an $11.9 million con.....»»

Category: topSource: marketwatchMar 24th, 2020

COVID-19 vaccine developer takes key step toward coronavirus trial in early summer

Vaxart Inc. will work with Emergent BioSolutions Inc. to develop and make the Peninsula company's oral vaccine candidate against the potentially deadly COVID-19 coronavirus. The move is an important step for a small South San Francisco company hoping.....»»

Category: topSource: bizjournalsMar 18th, 2020

The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues

Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off. The week was light on news flow, barring some smid-cap earnings and COVID-19 treatment and vaccine news. read more.....»»

Category: blogSource: benzingaMar 8th, 2020

ImmunityBio expands COVID-19 vaccine candidate trials

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 25th, 2021

Pfizer is testing a COVID-19 booster shot in combination with new pneumococcal conjugate vaccine candidate

Shares of Pfizer Inc. gained 0.1% in premarket trading on Monday after the company said it is testing its experimental 20-valent pneumococcal conjugate vaccine in combination with.....»»

Category: topSource: marketwatchMay 24th, 2021

: Swimsuits and luggage are hot items as U.S. shoppers prepare for summer events with relaxed COVID restrictions

Retailers are highlighting the categories that are on the upswing as the vaccine rollout continues and stimulus cash drives sales......»»

Category: topSource: marketwatchMay 18th, 2021

Medicago, GlaxoSmithKline report data from COVID-19 vaccine candidate trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 18th, 2021

The US is studying how COVID-19 vaccines work in people with suppressed immune systems - after research suggested they develop fewer antibodies from the shots

People with immune disorders were excluded from COVID-19 vaccine clinical tria.....»»

Category: personnelSource: nytMay 17th, 2021

Competing for tech talent? Give people the chance to change the world while advancing their careers

The talent crisis is poised for a comeback. The economic consequences of Covid-19 wiped out previously low unemployment rates in 2020, making it an employer’s market for many industries. As the vaccine rollout continues and the economy r.....»»

Category: topSource: bizjournalsMay 14th, 2021